A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma von Morschhauser, F., Seymour, J. F., Kluin-Nelemans, H. C., Grigg, A., Wolf, M., Pfreundschuh, M., Tilly, H., Raemaekers, J., van 't Veer, M. B., Milpied, N., Cartron, G., Pezzutto, A., Spencer, A., Reyes, F., Dreyling, M.

Volltext

17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation von Dijkstra, M K, van Lom, K, Tielemans, D, Elstrodt, F, Langerak, A W, van ‘t Veer, M B, Jongen-Lavrencic, M

Volltext

Visceral leishmaniasis after allogeneic hematopoietic stem cell transplantation von Agteresch, H J, van 't Veer, M B, Cornelissen, J J, Sluiters, J F

Volltext

Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma von VAN IMHOFF, G. W, VAN DER HOLT, B, RAEMAEKERS, J. M. M, SONNEVELD, P, MEULENDIJKS, L. A. M. H, KLUIN, P. M, KLUIN-NELEMANS, H. C, VERDONCK, L. F, MACKENZIE, M. A, OSSENKOPPELE, G. J, WIJERMANS, P. W, KRAMER, M. H. H, VAN 'T VEER, M. B, SCHOUTEN, H. C, VAN MARWIJK KOOY, M, VAN OERS, M. H. J

Volltext

Dynamics of circulating t(14;18)-positive cells during first-line and subsequent lines of treatment in follicular lymphoma von MANDIGERS, C. M. P. W, MEIJERINK, J. P. P, VAN'T VEER, M. B, MENSINK, E. J. B. M, RAEMAEKERS, J. M. M

Volltext

Two patients with acute thrombocytopenia following gold administration and five-year follow-up von LEVIN, M.-D, VAN T VEER, M. B, DE VELD, J. C, MARKUSSE, H. M

Volltext

A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patie... von de Wit, R, Kruit, WHJ, Lamers, CHJ, van 't Veer, MB, Luyten, AA, van Beurden, V, Harteveld, M, Planting, ASTh, Schmitz, PIM, Stoter, G, Bolhuis, RLH, Verweij, J

Volltext

Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations von Broeks, A, Russell, N S, Floore, A N, Urbanus, J H, Dahler, E C, van T Veer, M B, Hagenbeek, A, Noordijk, E M, Crommelin, M A, van Leeuwen, F E, van T Veer, L J

Volltext

Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that a... von Krol, Augustinus D.G, Berenschot, Henriëtte W.A, Doekharan, Dew, Henzen-Logmans, Sonja, van der Holt, Bronno, van ‘t Veer, Mars B

Volltext

Acquired von Willebrand Disease Caused by an Autoantibody Selectively Inhibiting the Binding of von Willebrand Factor to Collagen von van Genderen, Perry J.J., Vink, Tom, Michiels, Jan J., van’t Veer, Mars B., Sixma, Jan J., van Vliet, Huub H.D.M.

Volltext

Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen von van Genderen, PJ, Vink, T, Michiels, JJ, van 't Veer, MB, Sixma, JJ, van Vliet, HH

Volltext

Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia von Vojdeman, FJ, Herman, SEM, Kirkby, N, Wiestner, A, van, t' Veer MB, Tjonnfjord, GE, Itala-Remesg, MA, Kimby, E, Farooqui, MZ, Polliack, A

Volltext

Immune and nonimmune causes of low recovery from leukodepleted platelet transfusions: a prospective study von Levin, M-D, de Veld, J C, van der Holt, B, van 't Veer, M B

Volltext

Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies von VAN DEN BENT, M. J, LAMERS, C. H. J, VAN'T VEER, M. B, SMITT, P. A. E. Sillevis, BOLHUIS, R. L. H, GRATAMA, J. W

Volltext

Platelet‐bound immunogloblins before and after platelet transfusion: measurement of in vivo binding von Levin, M‐D., De Vries, W., De Veld, J., Doekharan, D., Van Der Holt, B., Van 'T Veer, M. B.

Volltext

Re: Late Effects From Radiation Therapy: The Hits Just Keep on Coming von Aleman, Berthe M. P., de Bruin, Marie L., Dorresteijn, Lucille D. A., Krol, Augustinus D. G., van ‘t Veer, Mars B., Boogerd, Willem, van Leeuwen, Flora E.

Volltext

Quality control of flow cytometric immunophenotyping of haematological malignancies von Gratama, J. W., Bolhuis, R. L. H., Van, M. B., Veer, 'T.

Volltext

Impact of Cardiovascular Counseling and Screening in Hodgkin Lymphoma Survivors von Daniëls, Laurien A., MD, Krol, Stijn D.G., MD, PhD, de Graaf, Michiel A., MSc, Scholte, Arthur J.H.A., MD, PhD, van ’t Veer, Mars B., MD, PhD, Putter, Hein, PhD, de Roos, Albert, MD, PhD, Schalij, Martin J., MD, PhD, van de Poll-Franse, Lonneke V., PhD, Creutzberg, Carien L., MD, PhD

Volltext

Leukaemia update. Part 1: diagnosis and management von Grigoropoulos, Nicholas F, Petter, Roger, Van ‘t Veer, Mars B, Scott, Mike A, Follows, George A

Volltext

Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation von Gerritsen, E J, Van Tol, M J, Van 't Veer, M B, Wels, J M, Khouw, I M, Touw, C R, Jol-Van Der Zijde, C M, Hermans, J, Rümke, H C, Radl, J

Volltext